Swedish Sleep Medicine is committed to using the most effective technology to diagnose and treat sleep disorders. Our goal is to improve patients' overall health and quality of life.
The STAR Trial
Swedish Sleep Medicine has been selected to participate in a pivotal clinical study to evaluate the safety and effectiveness of a new therapy for patients with moderate to severe obstructive sleep apnea (OSA). The STAR trial (Stimulation Therapy for Apnea Reduction) will be conducted at leading medical centers across the United States and Europe, and will evaluate the efficacy of Inspire™ Upper Airway Stimulation (UAS) therapy, an implantable therapy that works with the body’s natural physiology to prevent airway obstruction during sleep.
Click here to learn more.
For more information, contact Eastside Therapeutic Resources at www.etreasource.com.
VRS-317 (or Versartis)
Growth hormone deficiency study. For more information, contact Versartis at www.versartis.com.